Skip to content

Monosomy 8q21 Q22 Cn036327

Published: July 22, 2026Updated: August 20, 2026

A genetic condition involving deletion of a segment of chromosome 8 that may affect development and cause birth differences. Treatment requires supportive care tailored to each persons symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(congenital)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Intellectual disability

(neurological)

Growth retardation

(endocrine)

Characteristic facial features

(congenital)

Hand abnormalities

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Evidence-based pharmacological treatment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Systematic Multi-Organ Surveillance Protocol

Ongoing monitoring for cardiac defects, renal anomalies, and neurological involvement through regular imaging and specialist consultations appropriate to the monosomy 8q21-q22 region.

monitoring
3

Motor Development Optimization Program

Individualized physical therapy focusing on balance, coordination, and strength to maximize functional mobility and independence.

physical_therapy

Additional treatment options

Symptomatic Pharmaceutical Management

Targeted medication therapy for specific symptoms such as seizure management, gastrointestinal issues, or hormonal deficiencies when present, under specialist supervision.

medication

Structured Adaptive Living Programs

Comprehensive lifestyle support including occupational therapy for daily living skills, adaptive equipment assessment, and community integration services.

lifestyle

Behavioral and Emotional Support Services

Psychological interventions addressing anxiety, social difficulties, and behavioral regulation commonly seen in chromosomal deletion syndromes.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Monosomy 8q21 Q22 Cn036327?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Monosomy 8q21 Q22 Cn036327. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy